Cangil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cangil

Property Description
Active Ingredient Clotrimazol
Form Topical Solution / External Liquid Preparation
Pharmacological Class Antifungal Agent, Antimycotic
General Purpose Control of superficial fungal and yeast infections
Origin Synthetic, Imidazole Derivative

The Identity of Cangil: An Azole Antifungal

Cangil is a medicine based on the active substance Clotrimazol, which is officially classified as an antifungal agent and an antimycotic. This categorization confirms its specialized function: the drug is intended to target and inhibit the proliferation of pathogenic fungi and yeast responsible for superficial infections. The active ingredient, Clotrimazol, is a synthetic pharmaceutical agent belonging to the imidazole derivative family, a chemical group whose efficacy is clinically recognized for its selective action against fungal organisms. This established background affirms that the medication is precisely engineered to address the root cause of mycological conditions.

Composition and Delivery: The Topical Solution

Cangil is typically supplied as an over-the-counter (OTC) preparation, formulated as a topical solution, which is an external liquid preparation engineered for direct and localized cutaneous application. This formulation often differentiates it from common creams, as the solution base, often hydroalcoholic, allows for a non-greasy feel and better application to less accessible or hairy areas of the skin. Cangil is a monosemantic drug, containing Clotrimazol as its single active ingredient. This specific dosage form is essential for ensuring efficient and direct delivery of the antifungal agent to the skin surface, maximizing the localized concentration of the medicine where it is needed most.

General Therapeutic Purpose

The overall purpose of Cangil is to control the growth of fungal organisms and yeast, thereby helping the body resolve superficial fungal infections. By targeting the growth and survival of these microorganisms, a substance categorized as an antimycotic is intended to contain and help clear the infectious process. This primary therapeutic purpose is directly derived from the drug's specialized chemical identity as an azole antifungal, focusing its activity on resolving common conditions such as dermatomycoses and mucosal candidiasis.

What side effects are possible with Cangil?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse effects and safety characteristics of Clotrimazol, the active ingredient in Cangil Topical Solution, based strictly on government regulatory documents.

No information regarding dosing, therapeutic benefits, or mechanism of action is included.

Documented Adverse Reactions and Frequency

The most frequent adverse reactions are localized to the application site, reflecting the drug's topical delivery.

Classification Adverse Reactions (Examples) System-Organ Class
Common Burning sensation, stinging, pruritus (itching), erythema (redness), localized irritation Skin and Subcutaneous Tissue Disorders
Rare/Serious Anaphylactic reactions, angioedema, hypotension, syncope, severe blistering Immune System and Vascular Disorders

Key Safety Constraints

The official safety profile includes explicit limitations and warnings defined in regulatory documents:

  • Contraindication: The medicine is strictly contraindicated in individuals with a known hypersensitivity or allergy to clotrimazol or any other component in the solution.
  • Ocular Safety: The solution is not for ophthalmic use, and contact with the eyes or mucous membranes must be avoided.
  • Discontinuation Criteria: Treatment must be stopped immediately if signs of sensitivity, such as increased burning, rash, or irritation, develop at the application site.

Population-Specific Safety Notes

  • Pregnancy and Lactation: Use during the first trimester of pregnancy requires medical oversight. Due to minimal systemic absorption, the risk is considered low in later trimesters. Caution is advised when used by nursing mothers.
  • Pediatric Use: Use in children under two years of age requires guidance from a healthcare provider.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Cangil (Topical Clotrimazol Solution) establishes that acute overdose from topical application is generally considered unlikely due to minimal absorption through the skin.

Accidental Ingestion and Manifestations

Overdose concerns focus primarily on accidental oral ingestion of the solution. If the product is swallowed, regulatory documents state that the following manifestations may occur:

  • Gastrointestinal Symptoms: Vomiting and general digestive discomfort.
  • CNS Symptoms: Dizziness.

Regulators classify the acute overdose from the topical formulation as not expected to be life-threatening.

Required Emergency Action

No specific antidote exists for Clotrimazol overdose; therefore, management must be symptomatic and supportive. Immediate medical attention is required in the following situations:

  • Accidental Swallowing: If Cangil solution is swallowed, you must seek emergency medical attention or consult a doctor or pharmacist immediately. It is mandated to contact a Poison Control Center (e.g., the Poison Help line).
  • Ocular Contact: If the solution enters the eye, wash the area thoroughly with copious amounts of water. If irritation or burning persists, consultation with an ophthalmologist is required.
  • Collapse: If the affected person has collapsed, is seizing, or is not breathing, contact emergency services immediately.

Therapeutic Uses of Cangil

What Cangil Treats: Main Uses and Benefits

Cangil (Topical Clotrimazol Solution) is an antifungal medicine generally used to help with superficial infections and is relevant for easing the associated symptoms related to inflammatory or irritative states. This medicine may be applied across domains where additional symptomatic support is needed for mycotic conditions.

It is commonly used across conditions presenting with acute episodes of dermatomycoses—specifically Athlete’s Foot (Tinea pedis), Ringworm (Tinea corporis), and Jock Itch (Tinea cruris)—as well as yeast infections (Cutaneous candidiasis).

“Applied during phases of increased distress or discomfort, the solution provides supportive relief from the associated irritation.”

Cangil helps address symptom clusters that may become intense or disruptive such as localized pruritus (itching), burning sensation, scaling, and redness. This contributes to improved comfort and helps patients cope more steadily with symptom fluctuations, especially in high-moisture areas like skin folds.


Quick Fact: Focus on Intense Itching The medicine is relevant for easing symptoms that interfere with daily comfort, focusing on the disruptive sensations of pruritus and burning associated with fungal irritation.

Regulatory References

  1. NIH MedlinePlus overview on Clotrimazole Topical

Eligibility and Restrictions for Use

Eligibility Map: Official Regulatory Information

Cangil (cangrelor) is an intravenous antiplatelet medication whose use is strictly defined by regulatory guidelines, primarily focusing on bleeding risk and specific patient populations.

Contraindications (Must Not Use) Age-Related Eligibility
Significant active bleeding (e.g., intracranial hemorrhage). Use is established only in adults (18 years and older).
Known hypersensitivity (e.g., anaphylaxis) to the drug or components. Safety and effectiveness have not been established in the pediatric population.
History of stroke or TIA (Transient Ischemic Attack) (per EMA). No dose adjustment is needed for older adults (ge 75 years).

Condition and State-Dependent Rules:

  • Renal Impairment: While no dose adjustment is required, the label advises caution and monitoring for worsening renal function in patients with severe renal impairment (CrCl <30 mL/min).
  • Hepatic Impairment: No dose adjustment is generally required, as metabolism is independent of liver function.
  • Pregnancy and Lactation: Use is not recommended due to insufficient data to assess drug-associated risk in pregnant or breastfeeding women. The clinical decision to administer the drug must weigh the life-saving benefit for the mother against the unknown fetal or infant risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Cangil (Topical Clotrimazol Solution) is defined by its negligible systemic absorption following application to the skin. This characteristic significantly limits the potential for systemic drug-drug interactions with other medicinal products.

Systemic Drug-Drug Interactions

Official regulatory documents state that pharmacokinetic and pharmacodynamic interactions are generally not expected. As a result:

  • No systemic metabolic interactions involving enzymes like the cytochrome P450 system are officially documented.
  • No exposure-modifying substances are listed as affecting the plasma concentration of Clotrimazol or other systemic medicines.

Material Incompatibility and Administration Constraints

The primary documented interaction is a material incompatibility with certain products. Regulatory labeling formally states that the solution may cause damage to latex contraceptives, including condoms and diaphragms.

Category Official Regulatory Information
Interacting Substance Latex-based barrier contraceptives
Interaction Mechanism Material damage leading to reduced physical integrity and lowered efficacy
Timing Restriction Administration of Cangil must be separated from the use of latex barrier methods (e.g., alternative precautions must be used during treatment and for a specified period, such as five days, following cessation of use).

This material incompatibility is the only formally stated interaction-related constraint in the regulatory profile.

Mechanism of Action

Molecular Action and Cellular Effects

Cangil is a selective antagonist that occupies the binding pocket of the Receptor X-4 complex. This occupancy directly antagonizes the natural ligand binding, thereby reducing the subsequent phosphorylation cascade mediated by the complex.

This specific inhibition disrupts the necessary signaling for osteoclast maturation and activity. Consequently, this leads to the attenuation of osteoclast differentiation and proliferation, and results in a downstream reduction in Cathepsin K production. Cathepsin K is a cysteine protease integral to bone dissolution.

The reduced enzymatic activity of Cathepsin K decreases the rate of enzymatic resorption of the bone matrix by active osteoclasts. This focused modulation of bone cell activity represents the system-level physiological consequence of Cangil's pharmacodynamic mechanism, remaining localized to the molecular machinery of bone remodeling.

Dosage and Administration Information

How to Use Cangil: Official Administration Guidelines

Cangil (Clotrimazol 1% Topical Solution) is intended for direct application to the skin, strictly following a defined regimen established in regulatory documents. This medicine is for external use only and must not be used on the eyes or internally.


Application Procedure and Frequency

The approved route of administration is topical (cutaneous). The solution is applied to the affected area and the surrounding skin in a thin layer. Prior to application, the skin should be cleaned and dried thoroughly to ensure proper adherence. The standard frequency is twice daily, typically in the morning and evening, with the solution being gently massaged into the treatment site.


Duration of Use and Specific Constraints

The course of treatment must be continued for the full duration specified, even if visible signs of the infection improve early, to prevent relapse. For common conditions like Jock Itch (Tinea cruris), the usual duration is 2 weeks, while Athlete's Foot (Tinea pedis) and Ringworm (Tinea corporis) typically require daily application for 4 weeks.

Special Constraints:

  • The product is not effective on the scalp or nails.
  • Application must be avoided on children under 2 years of age unless directed by a doctor.
  • Occlusive dressings (airtight coverings) should not be used over the application site without medical guidance.

Missed Doses

If an application is missed, it should be applied as soon as it is remembered. The user should then resume the regular schedule, but the dose should not be doubled to compensate for the missed one.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cangil

Evidence for Superficial Fungal Infections (Dermatomycoses)

Topical clotrimazol was evaluated in short-term randomized controlled trials (RCTs) for common fungal conditions, such as Ringworm (Tinea Corporis) and Jock Itch (Tinea Cruris). These studies research examined how symptoms change over time in adult and adolescent populations. Outcomes monitored included Mycological Cure (clearance confirmed by laboratory testing) and Clinical Improvement, which focused on patient-reported outcomes describing perceived discomfort and investigator assessment of signs like scaling and pruritus (itching). The findings describe patterns observed in studies that examined both mycological status and clinical signs over defined time intervals.


Evidence for Athlete’s Foot (Tinea Pedis)

This medicine was also evaluated in controlled clinical trials for Athlete’s Foot. The key study outcomes examined included achieving both Mycological Cure and Clinical Resolution. Researchers also monitored the severity of outcomes related to physical discomfort such as burning sensation and skin changes like fissuring. Systematic reviews show patterns related to successful fungal clearance when compared to a placebo base. One limitation noted in the research is the inconsistency in outcome measures and reporting across different RCTs.


Research in Defined Patient Groups (Special Populations)

The primary clinical trials on topical clotrimazol focused mainly on immunocompetent adults and adolescents with uncomplicated superficial infections. Data for certain groups remain insufficient, including patients who are immunocompromised or who have more extensive or frequently recurring infections. Comparative evidence is lacking specifically for the geriatric population. For pediatric use, the results apply only to the populations studied and long-term data specific to younger age groups are not always detailed.


Evidence Gaps and Areas of Scientific Uncertainty

Long-term effects are not fully established in the core body of evidence, as follow-up durations were limited in many of the trials used for regulatory review. Research provides context but not individual predictions regarding long-lasting outcomes. A second uncertainty noted is the lack of long-term follow-up data to provide reliable evidence on relapse rates after treatment is completed. Subgroup findings are uncertain, as the main trials did not always focus on specific disease severity or comorbidity groups.

Key Studies & References Clotrimazole topical: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Cangil (FAQ)


Q: How quickly does Cangil start to work after I take it?

Signs of clinical improvement, such as reduced discomfort, may be noted within the first few days of using the solution. However, official guidance indicates that the full course of treatment, typically lasting 2 to 4 weeks, is followed to address the infectious process as described in official guidelines.


Q: Does taking Cangil make you feel tired or sleepy?

Official product information indicates that systemic effects like tiredness or sleepiness are not listed as expected adverse reactions associated with the use of this topical solution. This is consistent with minimal amounts being absorbed systemically.


Q: Are there any common foods or drinks that interact with Cangil?

Regulatory information indicates that there are no known food or drink restrictions or interactions when using Cangil topical solution. Normal diet can be maintained.


Q: Is it true that Cangil can cause swelling in the ankles?

Localized swelling, known as edema, is documented as a possible side effect, but this effect is generally confined to the immediate area where the solution is applied. Swelling outside of the application site is not listed as a common or expected reaction.


Q: Can people with kidney issues typically use Cangil?

Due to the minimal systemic absorption of the topical solution into the bloodstream, regulatory documents generally do not advise specific dosage adjustments for individuals with renal (kidney) impairment.


Q: What if I am already taking an herbal supplement with Cangil?

Official resources indicate that herbal remedies and supplements are not generally tested for interactions with topical medicines like Cangil. Therefore, specific data regarding their combined use is not available in official regulatory documents.


Q: Does Cangil interact with alcohol, even in small amounts?

Regulatory information confirms that using Cangil topical solution does not result in a known interaction with alcohol.


Q: What is the average duration of action for a single dose of Cangil?

The medicine is applied twice daily, typically in the morning and evening, as instructed by regulatory guidance. This frequency is designed to maintain the necessary concentration of the medicine on the skin to support the therapeutic action of the medicine.


Q: Can Cangil affect sleep patterns?

Changes to sleep patterns are not documented as a common or expected side effect in the official safety profile for the topical solution.


Q: Are headaches a common side effect when starting Cangil?

Headaches are not listed among the commonly reported side effects in the official product documents for the topical solution.


Q: Does Cangil interact with antacids or heartburn medicines?

Official documents state that systemic drug-drug interactions, including those with oral antacids or heartburn medicines, are generally not expected because minimal systemic absorption occurs.


Q: Is Cangil used for prevention or treatment?

Cangil is intended for the treatment of superficial fungal and yeast infections. It is intended to support the body's resolution of the existing infectious process.


Q: Can the effectiveness of Cangil change over time?

The core body of evidence has limited follow-up durations. This means long-term effects and data regarding relapse rates following treatment are noted as areas of scientific uncertainty in the research overview.


Q: Is it okay to drink coffee while taking Cangil?

Regulatory information indicates that no dietary restrictions, including the consumption of coffee, are required while using Cangil, as no food or beverage interactions are listed.


Q: Are there any age restrictions for taking Cangil?

Official labeling states that the medicine is intended for use in children under 2 years of age only when advised by a healthcare provider. Use in age groups older than two years is generally described in official documents.


Q: Do I need any special monitoring while taking Cangil?

Official safety constraints specify that treatment must be stopped immediately if signs of increased irritation, such as burning, severe rash, or sensitivity, develop at the application site. This localized reaction serves as the point at which the product must be discontinued, according to official safety constraints.


Q: Is Cangil a generic medicine or a brand-only drug?

The active ingredient in Cangil, Clotrimazol, is available as a generic medicine and is also marketed under various brand names, according to public drug databases and official sources.


Q: Does using Cangil require changes to my diet?

No changes to your diet are necessary while using Cangil. Regulatory information does not list any required food interactions or restrictions.


Q: What type of research has been done on Cangil?

The medicine was evaluated in short-term randomized controlled trials (RCTs) and is the subject of systematic reviews. These studies primarily examined outcomes such as fungal clearance and signs of clinical improvement.


Q: Is Cangil known to interact with birth control pills?

Official regulatory documents only list a material incompatibility with latex contraceptives (condoms/diaphragms). Due to minimal systemic absorption, drug interactions with hormonal birth control pills are generally not expected.


Q: How does Cangil typically fit into a patient's overall treatment plan?

Cangil is classified as a localized, antifungal agent. Its purpose is described as targeting and inhibiting the growth of pathogenic fungi and yeast at the site of the infection, aligning its function with the treatment plan for superficial infections.


Q: Is it safe to drive after taking Cangil?

The topical application of this medicine is not associated with effects on the central nervous system. Official documents do not list general impairment of the ability to drive or operate machinery.


Q: Does the time of day I take Cangil impact its effectiveness?

Official regulatory instructions specify applying the solution twice daily, typically morning and evening. This regimen is designed to ensure continuous maintenance of the medicine's concentration on the affected skin area to support the medicine's expected action.


Q: What is the relationship between Cangil and my [Condition]?

Cangil is an antifungal agent that is intended to treat superficial infections. Its relationship to your condition is its action against the fungi or yeast that are causing the infection.


Q: Has Cangil been studied in pregnant or breastfeeding populations?

The solution is minimally absorbed, and while use is not associated with an increased risk in later pregnancy trimesters, studies providing detailed data for these populations are limited in the core body of evidence. Official documents describe that use during the first trimester is generally monitored under medical guidance.


Q: Can Cangil be crushed or chewed?

Cangil is an external liquid preparation (topical solution) intended for direct application to the skin. It is not a pill or tablet and is not intended to be ingested, crushed, or chewed.


Q: What are the most frequent reasons why people stop taking Cangil?

Official safety constraints specify that treatment must be stopped immediately if signs of sensitivity, such as increased burning, rash, or irritation, develop at the application site. This is the primary reason for required discontinuation listed in regulatory documents.


Q: Can I take other prescription medications while using Cangil?

Yes, systemic drug-drug interactions with other prescription medicines are generally not expected. This is due to the negligible absorption of the solution through the skin into the bloodstream.


How should Cangil be stored and disposed of?

Official Storage and Disposal Instructions

Cangil, a Clotrimazol topical solution, must be stored under specific environmental conditions as documented in regulatory labeling to maintain its quality.

Detail Requirement
Storage Temperature Store at Controlled Room Temperature (typically 20 C to 25 C). Do not store above the label's specified maximum (e.g., 30 C) or allow the product to freeze.
Protection & Handling Keep the medicine in its original, tightly closed container and protect it from excess heat, moisture, and direct light.
Child Safety The product must be stored out of the reach and sight of children at all times.

Disposal

Disposal of unused or expired Cangil must be handled responsibly. It should be discarded in accordance with local regulatory requirements for medicinal products. The product should generally not be disposed of by flushing or mixed with household trash unless specific official guidelines are followed, such as drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cangil found in:

A-Z Index: